首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cost Effectiveness And Resource Allocation

Cost Effectiveness And Resource Allocation杂志,由BMC出版,于2003年创刊,1 issue/year,出版语言English,ISSN:1478-7547,E-ISSN:1478-7547。

投稿咨询
Cost Effectiveness And Resource Allocation
Cost Effectiveness And Resource Allocation
Cost Effectiveness And Resource Allocation
SCIE SSCI

杂志介绍

JCR分区
Q1
中科院分区
3区
影响因子
3.1
CiteScore
3.9
期刊收录
SCIE、SSCI

Cost Effectiveness And Resource Allocation(中文译名:《成本效益和资源配置》),ISSN:1478-7547,EISSN:1478-7547,是BMC出版的国际性学术期刊,创刊于2003年,以1 issue/year形式稳定发行,2026年总发文量约96篇。该刊采用OA开放访问,学科归属为HEALTH POLICY & SERVICES。该刊是医学、卫生政策与服务领域的国际权威刊物,已被SCIE(科学引文索引扩展版)、SSCI(社会科学引文索引)等国际主流学术数据库收录。2026年期刊影响因子达3.1,2025年期刊CiteScore为3.9,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Cost Effectiveness And Resource Allocation长期聚焦医学、卫生政策与服务及相关产业的技术应用前沿,平均审稿周期34 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、卫生政策与服务领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、CHINA MAINLAND、Iran、Canada、GERMANY (FED REP GER)、Netherlands等为核心发文国家与地区;HARVARD UNIVERSITYSHIRAZ UNIVERSITY OF MEDICAL SCIENCE、UNIVERSITY OF LONDON、IRAN UNIVERSITY OF MEDICAL SCIENCES、WORLD HEALTH ORGANIZATION、ADDIS ABABA UNIVERSITY、GLAXOSMITHKLINE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
HEALTH POLICY & SERVICES 卫生政策与服务
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEALTH POLICY & SERVICES 卫生政策与服务
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
HEALTH POLICY & SERVICES 卫生政策与服务
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH POLICY & SERVICES SSCI Q1 31 / 125

75.6

学科:HEALTH POLICY & SERVICES SSCI Q2 56 / 125

55.6

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH POLICY & SERVICES SSCI Q3 76 / 118

36

学科:HEALTH POLICY & SERVICES SSCI Q3 71 / 119

40.76


中国学者近期发文

1
Comparison of national health planning policies in China and ASEAN: a PMC-index model analysi

Author:Feng, Jun; Zhu, Chenting; Chen, Yujun; Huang, Lingbo; Huang, Qian; Qin, Yiming; Wei, Junyuan; Li, Zhen; Feng, Qiming; Qin, Xianjing; Kang, Jing

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12962-026-00728-x

2
Urban welfare and family-oriented settlement intentions of China's floating populatio

Author:Yang, Weining; Zhu, Xiaoli; Xia, Yuntian

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12962-026-00719-y

3
Equity in health resource allocation in Guangdong Province, China, from 2013-2021: research based on the Dagum Gini coefficient and exploratory spatial data analysi

Author:Su, Wanmin; Guan, Ziyun; Li, Xiao; Chen, Feixiang; Guo, Panxu; Yuan, Chuanxiang; Wang, Peixi

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12962-026-00714-3

4
A comparative health economic evaluation of venetoclax in combination with obinutuzumab versus Chlorambucil in combination with obinutuzumab as first-line treatment for chronic lymphocytic leukemia in China: a cost-effectiveness analysi

Author:Du, Jiatai; Ran, Hanglin; Zheng, Zhou; Yu, Xihe; Feng, Tianyu

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12962-025-00705-w

5
Assessing the relationship between the hospital grading system and medical resource utilization: evidence from Chin

Author:Jia, Wanwen; Wu, Xiaoli

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12962-025-00672-2

6
Pembrolizumab plus chemotherapy in advanced endometrial cancer: a cost-effectiveness analysi

Author:Zhao, Xinqiang; She, Longjiang; Liu, Xiaoning; Bi, Zhenggang

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2025; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12962-025-00625-9

7
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study in 202

Author:Sun, Tianqi; Yu, Tianfu; Liu, Pengcheng

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2025; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12962-025-00635-7

8
Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysi

Author:Zhou, Dachuang; Zhang, Di; Wang, Yi; Zhou, Kejia; Tang, Wenxi

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2025; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12962-025-00630-y

9
Impact of China's diagnosis-intervention packet payment reform on pediatric pneumonia hospitalization costs: an interrupted time series analysi

Author:Zhao, Liang; Zeng, Kun; Chen, Feijia; Li, Wei; Zhao, Jun

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2025; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12962-025-00623-x

10
Cost-utility analysis of olaparib assisted targeted therapy for BRCA mutation HER2-negative early breast cancer in China and in the United State

Author:Xu, Chenxia; Zhuang, Jie; Shen, Jianrong; Sun, Hong; Cai, Jiaqin; Wei, Xiaoxia

Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2025; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12962-025-00617-9


在线咨询

Cost Effectiveness And Resource Allocation

国际简称:COST EFFECT RESOUR A参考译名:成本效益和资源配置

年发文量:96 CiteScore:3.9 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:89.58%

杂志社联系方式:Cost Effect. Resour Alloc.

Cost Effectiveness And Resource Allocation